Humacyte HUMA
NASDAQ HUMA
$0.68 -0.05 (-6.85%)
At close: Aug 20, 2026 · 4:00 PM EDT

Humacyte (HUMA) Debt Ratio (2020 - 2026)

Humacyte (HUMA) posted quarterly Debt Ratio of 0.32 for Q1 2026, down 22.5% year-over-year from 0.42 in Q1 2025, and up 6.52% quarter-over-quarter from 0.3 in Q4 2025.

Humacyte (HUMA) Debt Ratio (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Debt Ratio for 7 consecutive years, with 0.32 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio fell 22.5% year-over-year to 0.32; the TTM figure through Mar 2026 stood at 0.32 (down 22.5% YoY), while the FY2025 annual figure was 0.3, up 4645.14% from the prior year.
  • Debt Ratio advanced to 0.32 in Q1 2026 per HUMA's latest filing, from 0.3 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.54 in Q3 2024 and bottomed at 0.01 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.26 across 5 years, with a median of 0.25 in 2023.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 105486.14% — and 2024, when it tumbled 97.87%.
  • Humacyte's Debt Ratio stood at 0.14 in 2022, then surged by 112.76% to 0.3 in 2023, then sank by 97.87% to 0.01 in 2024, then jumped by 4645.14% to 0.3 in 2025, then gained by 6.52% to 0.32 in 2026.
  • Business Quant data shows HUMA's Debt Ratio at 0.32 in Q1 2026, 0.3 in Q4 2025, and 0.23 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.05
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.26
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.47
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.03
10 Humacyte 158.12 Mn 158.12 Mn -825,000.00 0.26

Historic Data

Download Data
DateValue
Jun 30, 2026 0.26
Mar 31, 2026 0.32
Dec 31, 2025 0.30
Sep 30, 2025 0.23
Jun 30, 2025 0.51
Mar 31, 2025 0.42
Dec 31, 2024 0.01
Sep 30, 2024 0.54
Jun 30, 2024 0.43
Mar 31, 2024 0.36
Dec 31, 2023 0.30
Sep 30, 2023 0.25
Jun 30, 2023 0.22
Mar 31, 2023 0.07
Dec 31, 2022 0.14
Sep 30, 2022 0.13
Jun 30, 2022 0.12
Mar 31, 2022 0.10
Dec 31, 2021 0.10
Sep 30, 2021 0.06